Chest, Vol 92, 57-62, Copyright © 1987 by American College of Chest Physicians

ARTICLES

Comparison of progressive exercise performance of normal subjects and patients with primary pulmonary hypertension

GE D'Alonzo, LA Gianotti, RL Pohil, RR Reagle, SL DuRee, F Fuentes and DR Dantzker

The extent of exercise limitation and the mechanisms for that limitation in 11 patients with primary pulmonary hypertension (PPH) were studied by progressive, upright cycle ergometry. All patients had a mean pulmonary artery pressure of 30 mm Hg or higher (mean, 56 +/- 15), normal pulmonary function testing, normal pulmonary capillary wedge pressure, and pulmonary angiography consistent with the diagnosis. Rest and exercise data obtained from the patients with PPh were compared with data obtained from 11 matched, sedentary control subjects. Mean maximal oxygen consumption (VO2) was 13 +/- 4 ml/kg/min in the PPH group compared with 28 +/- 7 ml/kg/min in the controls. At maximal VO2 the minute ventilation (VE) was similar; however, the VE at any level of carbon dioxide production (VCO2) during rest and exercise was significantly higher in the PPH group. Maximal heart rate and oxygen pulse (VO2/heart rate) was significantly higher in the control group (148 +/- 18 vs 180 +/- 24, and 6.3 +/- 2.2 vs 9.9 +/- 3.9, respectively). Anaerobic threshold occurred earlier during progressive exercise in the PPH group and correlated positively with the maximal oxygen pulse achieved in patients with PPH. In conclusion, patients with PPH have severe exertional limitation due to cardiovascular factors with an inability to maintain appropriate oxygen delivery to the body during exercise. No respiratory impairment was recognized; however, an exaggerated ventilatory response to exercise at any level of VCO2 was found.

This article has been cited by other articles:

				J. E. Hansen, G. Ulubay, B. F. Chow, X.-G. Sun, and K. Wasserman Mixed-Expired and End-Tidal CO2 Distinguish Between Ventilation and Perfusion Defects During Exercise Testing in Patients With Lung and Heart Diseases Chest, September 1, 2007; 132(3): 977 - 983. [Abstract] [Full Text] [PDF]

				R. Naeije Breathing more with weaker respiratory muscles in pulmonary arterial hypertension Eur. Respir. J., January 1, 2005; 25(1): 6 - 8. [Full Text] [PDF]

				S. Velez-Roa, A. Ciarka, B. Najem, J.-L. Vachiery, R. Naeije, and P. van de Borne Increased Sympathetic Nerve Activity in Pulmonary Artery Hypertension Circulation, September 7, 2004; 110(10): 1308 - 1312. [Abstract] [Full Text] [PDF]

				G. Deboeck, G. Niset, M. Lamotte, J-L. Vachiery, and R. Naeije Exercise testing in pulmonary arterial hypertension and in chronic heart failure Eur. Respir. J., May 1, 2004; 23(5): 747 - 751. [Abstract] [Full Text] [PDF]

				H. H. Leuchte, M. Holzapfel, R. A. Baumgartner, I. Ding, C. Neurohr, M. Vogeser, T. Kolbe, M. Schwaiblmair, and J. Behr Clinical significance of brain natriuretic peptide in primary pulmonary hypertension J. Am. Coll. Cardiol., March 3, 2004; 43(5): 764 - 770. [Abstract] [Full Text] [PDF]

				N. Nagaya, S. Kyotani, M. Uematsu, K. Ueno, H. Oya, N. Nakanishi, M. Shirai, H. Mori, K. Miyatake, and K. Kangawa Effects of Adrenomedullin Inhalation on Hemodynamics and Exercise Capacity in Patients With Idiopathic Pulmonary Arterial Hypertension Circulation, January 27, 2004; 109(3): 351 - 356. [Abstract] [Full Text] [PDF]

				X.-G. Sun, J. E. Hansen, R. J. Oudiz, and K. Wasserman Pulmonary function in primary pulmonary hypertension J. Am. Coll. Cardiol., March 19, 2003; 41(6): 1028 - 1035. [Abstract] [Full Text] [PDF]

				ATS/ACCP Statement on Cardiopulmonary Exercise Testing Am. J. Respir. Crit. Care Med., January 15, 2003; 167(2): 211 - 277. [Full Text] [PDF]

				R. Wensel, C. F. Opitz, S. D. Anker, J. Winkler, G. Hoffken, F. X. Kleber, R. Sharma, M. Hummel, R. Hetzer, and R. Ewert Assessment of Survival in Patients With Primary Pulmonary Hypertension: Importance of Cardiopulmonary Exercise Testing Circulation, July 16, 2002; 106(3): 319 - 324. [Abstract] [Full Text] [PDF]

				K. G. Tantisira, D. M. Systrom, and L. C. Ginns An Elevated Breathing Reserve Index at the Lactate Threshold Is a Predictor of Mortality in Patients with Cystic Fibrosis Awaiting Lung Transplantation Am. J. Respir. Crit. Care Med., June 15, 2002; 165(12): 1629 - 1633. [Abstract] [Full Text] [PDF]

				N Nagaya, Y Shimizu, T Satoh, H Oya, M Uematsu, S Kyotani, F Sakamaki, N Sato, N Nakanishi, and K Miyatake Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary or thromboembolic pulmonary hypertension Heart, April 1, 2002; 87(4): 340 - 345. [Abstract] [Full Text] [PDF]

				M. S. Riley, J.a. Porszasz, M. P. K. J. Engelen, S. M. Shapiro, B. H. Brundage, and K. Wasserman Responses to constant work rate bicycle ergometry exercise in primary pulmonary hypertension: the effect of inhaled nitric oxide J. Am. Coll. Cardiol., August 1, 2000; 36(2): 547 - 556. [Abstract] [Full Text] [PDF]

				R. Wensel, C. F. Opitz, R. Ewert, L. Bruch, and F. X. Kleber Effects of Iloprost Inhalation on Exercise Capacity and Ventilatory Efficiency in Patients With Primary Pulmonary Hypertension Circulation, May 23, 2000; 101(20): 2388 - 2392. [Abstract] [Full Text] [PDF]

				S. MIYAMOTO, N. NAGAYA, T. SATOH, S. KYOTANI, F. SAKAMAKI, M. FUJITA, N. NAKANISHI, and K. MIYATAKE Clinical Correlates and Prognostic Significance of Six-minute Walk Test in Patients with Primary Pulmonary Hypertension . Comparison with Cardiopulmonary Exercise Testing Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 487 - 492. [Abstract] [Full Text]

				D. Wax, R. Garofano, and R. J. Barst Effects of Long-term Infusion of Prostacyclin on Exercise Performance in Patients With Primary Pulmonary Hypertension Chest, October 1, 1999; 116(4): 914 - 920. [Abstract] [Full Text] [PDF]